Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: Implications supporting the premise that hCG protects women against breast cancer

Biology of Reproduction

Volumn 57, Issue 5, 1997, Pages 1202-1210

  Lojun, S ^a,c   Bao, S ^a   Lei, Z M ^a   Rao, Ch V ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; ESTRADIOL; ESTRADIOL RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GROWTH; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; RNA TRANSCRIPTION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CHORIONIC GONADOTROPIN; DENSITOMETRY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; RECEPTORS, ESTROGEN; RECEPTORS, LH;

BOVINAE; MINK CELL FOCUS-FORMING VIRUS;

EID: 0030862409     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod57.5.1202     Document Type: Article

References (62)

1. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981; 50:466-495.
2. Lapthorn AJ, Harris DC, LittleJohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994; 369:455-461.
3. Loosfelt H, Misrahi M, Atger M, Salesse R, Vu MT, Thi HL, Jolivet A, Guiochon-Mantell A, Sar S, Jallal B, Gamier J, Milgrom E. Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. Science 1989; 245:525-528.
4. McFarland KC, Sprengel R, Phillips HS, Köhler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH. Lutropin-choriogonadotropin receptor: an unusual member of the G-protein coupled receptor family. Science 1989; 245:494-499.
5. Rao ChV. The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol 1996; 47:41-53.
6. Tao Y-X, Lei ZM, Rao ChV. The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sci 1997; 60:1297-1303.
7. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997; 57:857-864.
8. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning - A Laboratory Manual, ed 2. New York: Cold Spring Harbor Laboratory; 1989: 7.12-7.52, 10.27-10.36.
9. Dunn SD. Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on western blots by monoclonal antibodies. Anal Biochem 1986; 157: 144-153.
10. Keinänen KP, Kellokumpu S, Rajaniemi HJ. Visualization of the rat ovarian lutropin receptor by ligand blotting. Mol Cell Endocrinol 1987; 49:33-38.
11. Rao ChV, Griffin LP, Carman FR Jr. Gonadotropin receptors in human corpora lutea of the menstrual cycle and pregnancy. Am J Obstet Gynecol 1977; 128:146-153.
12. Reshef E, Lei ZM, Rao ChV, Pridham D, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol & Metab 1990; 70:421-430.
13. Slayden OD, Hirst JJ, Brenner RM. Estrogen action in the reproductive tract during antiprogestin treatment. Endocrinology 1993; 132: 1845-1856.
14. Planchon P, Weber N. Alteration of prostaglandin E receptors in advanced breast tumor cell lines. Mol Cell Endocrinol 1995; 111:219-223.
15. Steel RGD, Torrie JH. Principles and Procedures of Statistics, with Special Reference to the Biological Sciences. New York: McGraw-Hill; 1960.
16. Lei ZM, Toth P, Rao ChV, Pridham D. Novel co-expression of human chorionic gonadotropin/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol & Metab 1993; 77:863-871.
17. Rao ChV, Li X, Toth P, Lei ZM, Cook VD. Novel expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human umbilical cords. J Clin Endocrinol & Metab 1993; 77:1706-1714.
18. Lei ZM, Rao ChV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993; 132:2262-2270.
19. Lin J, Lojun S, Lei ZM, Wu WX, Peiper SC, Rao ChV. Lymphocytes from pregnant women express human chorionic gonadotropin/luteinizing hormone receptor gene. Mol Cell Endocrinol 1995; 111:R13-R17.
20. Pabon JE, Bird JS, Li X, Huang Z-H, Lei ZM, Sanfilippo J, Yussman MA, Rao ChV. Human skin contains luteinizing hormone/chorionic gonadotropin receptors. J Clin Endocrinol & Metab 1996; 81:2738-2741.
21. Kornyei J, Lei ZM, Rao ChV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod 1993; 49:1149-1157.
22. Lei ZM, Rao ChV. Novel presence of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and the down-regulating action of hCG on gonadotropin releasing hormone gene expression in immortalized hypothalamic GT1-7 neurons. Mol Endocrinol 1994; 8: 1111-1121.
23. Toth P, Li X, Rao ChV, Lincoln SR, Sanfilippo JS, Spinnato II JA, Yussman MA. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol & Metab 1994; 79:307-315.
24. Huang Z-H, Lei ZM, Rao ChV. Immortalized anterior pituitary αT3 gonadotropes contain functional luteinizing hormone/human chorionic gonadotropin receptors. Mol Cell Endocrinol 1995; 114:217-222.
25. Han S-W, Lei ZM, Rao ChV. Upregulation of cyclooxygenase-2 gene expression by chorionic gonadotropin in mucosal cells from human fallopian tubes. Endocrinology 1996; 137:2929-2937.
26. Toth P, Li X, Lei ZM, Rao ChV. Expression of human chorionic gonadotropin (hCG)/luteinizing hormone receptors and regulation of the cyclooxygenase-1 gene by exogenous hCG in human fetal membranes. J Clin Endocrinol & Metab 1996; 81:1283-1288.
27. Lin J, Lei ZM, Lojun S, Rao ChV, Satyaswaroop PG, Day TG Jr. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol & Metab 1994; 79:1483-1491.
28. Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 1978; 38:2434-2437.
29. Weigel RJ, deConinck EC. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 1993; 53: 3472-3474.
30. Alvarado MV, Russo J, Alvarado NE, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro Cell & Dev Biol 1994; 30A:4-8.
31. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976; 36:4595-4601.
32. Mac-Mahon B, Cole P, Liu M, Lowe CR, Mirra AP, Ravinihar B, Salber EG, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull WHO 1970; 43:209-221.
33. Trapido EJ. Age at first birth, parity, and breast cancer risk. Cancer 1983; 51:946-948.
34. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36-47.
35. Russo IH, Russo J. Chorionic gonadotropin: a tumoristatic and preventive agent in breast cancer. Teicher BA (ed.), Drug Resistance in Oncology. New York: Marcel Dekker; 1993: 537-560.
36. Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 1990; 62:243-247.
37. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990; 82:1286-1289.
38. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 1990; 11:1849-1855.
39. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 1991; 64:481-484.
40. Alvarado MV, Russo J, Russo IH. Immunolocalization of inhibin in the mammary gland of rats treated with hCG. J Histochem Cytochem 1993; 41:29-34.
41. Alvarado MV, Ho TY, Russo J, Russo IH. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and mammary gland of rat. Endocrine 1994; 2:1107-1114.
42. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers & Prevent 1994; 3:353-364.
43. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers & Prevent 1995; 4:437-440.
44. Russo IH, Russo J. Role of hCG and inhibin in breast cancer (review). Int J Oncol 1994; 4:297-306.
45. Russo J, Russo IH. Hormonally induced differentiation: a novel approach to breast cancer prevention. J Cell Biochem Suppl 1995; 22:58-64.
46. Kellen JA, Kolin A, Mirakian A, Acevedo HF. Effects of antibodies to choriogonadotropin in malignant growth. II. Solid transplantable rat tumors. Cancer Immunol Immunother 1982; 13:2-4.
47. Acevedo HF, Raikow RB, Powell JE, Stevens VC. Effects of immunization against human choriogonadotropin on the growth of transplanted Lewis lung carcinoma and spontaneous mammary adenocarcinoma in mice. Cancer Detect Prevent 1987; 1(suppl):477-486.
48. Naughton MA, Merrill DA, McManus LM, Fink LM, Berman E, White MJ, Martinez-Hernandez A. Localization of the β chain of human chorionic gonadotropin on human tumor cells and placental cells. Cancer Res 1975; 35:1887-1890.
49. Tormey DC, Waalkes TP, Simon RM. Biological markers in breast carcinoma. Cancer 1977; 39:2391-2396.
50. Walker RA. Significance of α-subunit hCG demonstrated in breast carcinomas by the immunoperoxidase technique. J Clin Pathol 1978; 31:245-249.
51. Wachner R, Wittekind C, Von Kleist S. Immunohistological localization of β-hCG in breast carcinomas. Eur J Cancer Clin Oncol 1984; 20:679-684.
52. Braunstein GD. Placental proteins as tumor markers. Heberman RB (ed)., Immunodiagnosis of Cancer. New York: Mercer, D.W., New York; Marcel Dekker; 1990: 673-701.
53. Agnantis NJ, Patra F, Khaldi L, Filis S. Immunohistochemical expression of subunit beta HCG in breast cancer. Eur J Gynaecol Oncol 1992; 13:461-466.
54. Acevedo HF, Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ, Hartsock RJ. Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 1992; 69:1829-1842.
55. Tao Y-X, Bao S, Ackermann DM, Lei ZM, Rao ChV. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma. Biol Reprod 1997; 56:67-72.
56. Bao S, Lei ZM, Rao ChV. The presence of functional luteinizing hormone/chorionic gonadotropin receptors in human prostate cell lines. In: Program of the Endocrine Society Annual Meeting; 1997; Abstract P3-403.
57. Gillot DJ, Iles RK, Chard T. The effects of β-human chorionic gonadotropin on the in-vitro growth of bladder cancer cell lines. Br J Cancer 1996; 73:323-326.
58. Rivera RT, Pasion SG, Wong DT. Loss of tumorigenic potential by human lung tumor cells in the presence of antisense RNA specific to the ectopically synthesized alpha subunit of human chorionic gonadotropin. J Cell Biol 1989; 108:2423-2434.
59. Kumar S, Talwar GP, Biswas DK. Necrosis and inhibition of growth of human lung tumor by anti-α human chorionic gonadotropin antibody. J Natl Cancer Inst 1992; 84:42-47.
60. Nagamani M, Cao HA. Specific binding and proliferative effects of luteinizing hormone in human endometrial cancer cell lines. J Soc Gynecol Invest 1997; 4:(suppl 1):abstract 211.
61. Konishi I, Koshiyama M, Mandai M, Yamamoto S, Nanbu K, Komatsu T, Kuroda H, Rao ChV, Mori T. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol 1997; 65:273-280.
62. Lei ZM, Taylor DD, Gercel-Taylor C, Rao ChV. Tumorigenic potential of human chorionic gonadotropin in choriocarcinoma JAR cells. J Soc Gynecol Invest 1996; 3(suppl 2):abstract 99.